Inogen, Inc.

NASDAQ:INGN

Medical - Devices

Healthcare
$5.42 +0.71%

+$0.05 today

Market cap
$140.93M
Beta
1.60
P/E (TTM)
-7.0
EPS (TTM)
-$0.91
52W Low $5.34High $9.13

Volume 0.22M

Average 0.33M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$11.22M

FY 2025 · Annual

Investing Cash Flow

-$26.21M

FY 2025 · Annual

Financing Cash Flow

$24.18M

FY 2025 · Annual

+9025.3% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(6.33M)(83.77M)(102.45M)(35.89M)(22.75M)
Depreciation & Amortization21.63M23.51M18.15M21M20.66M
Deferred Income Tax14.44M0(251K)(1.15M)(1.1M)
Stock-Based Compensation10.94M12.28M7.43M7.4M8.01M
Change in Working Capital(20.07M)(44.72M)14.27M(4.39M)(26.91M)
Accounts Receivables(5.42M)(51.62M)11.13M(5.07M)(14.62M)
Inventory(10.78M)(5.6M)7.88M(3.54M)(3.21M)
Accounts Payables(6.48M)6.76M(9.18M)(3.41M)5.6M
Other Working Capital2.61M5.74M4.44M7.63M(14.68M)
Other Non-Cash Items3.02M55.16M59.62M18.94M10.87M
Operating Cash Flow23.63M(37.53M)(3.23M)5.91M(11.22M)
Capital Expenditures(23.94M)(21.22M)(26.52M)(17.09M)(10.38M)
Acquisitions (Net)153K331K(29.44M)00
Purchases of Investments(9.99M)0(26.87M)(32.66M)(29.83M)
Sales of Investments19.26M10.01M24M35.5M14M
Other Investing Activities000(1.82M)0
Investing Cash Flow(14.65M)(10.88M)(59.32M)(13.98M)(26.21M)
Debt Repayment00000
Common Stock Issued15.65M1.74M1.48M811K28.18M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(647K)(1.36M)(518K)(546K)(4M)
Financing Cash Flow15M380K960K265K24.18M
Effect of Forex Changes(426K)(481K)67K(281K)846K
Net Change in Cash23.56M(48.51M)(61.52M)(8.08M)(12.4M)
Free Cash Flow(302K)(58.75M)(29.75M)(11.18M)(21.6M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$22.7M
+ D&A$20.7M
+ Stock-Based Comp$8.0M
- Deferred Tax-$1.1M
- Working Capital-$26.9M
+ Other Non-Cash$10.9M
= Operating Cash Flow-$11.2M
- Capex-$10.4M
= Free Cash Flow-$21.6M

Analysis

FY2025 free cash flow is -$21.6M. FCF conversion is 95.0% of net income. Operating cash flow was -$11.2M, with capex of -$10.4M. The largest bridge item is Working Capital at -$26.9M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportSep 30, 2026
4Statement of changes in beneficial ownershipSep 3, 2026
4Statement of changes in beneficial ownershipSep 3, 2026

Does INGN generate free cash flow?

Inogen, Inc. (INGN) generated -$21.60M of free cash flow in fiscal 2025.

How much operating cash flow does INGN produce?

Operating cash flow was -$11.22M, before capital expenditures of $10.38M.